461 related articles for article (PubMed ID: 17150303)
21. Neoadjuvant endocrine therapy for breast cancer: an overlooked option?
Wong ZW; Ellis MJ
Oncology (Williston Park); 2004 Apr; 18(4):411-20; discussion 421, 424, 429 passim. PubMed ID: 15134351
[TBL] [Abstract][Full Text] [Related]
22. What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?
Prowell TM; Davidson NE
Oncologist; 2004; 9(5):507-17. PubMed ID: 15477635
[TBL] [Abstract][Full Text] [Related]
23. [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
Kahlert S; von Koch F; Ditsch N; Untch M
Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):102-12. PubMed ID: 15073439
[TBL] [Abstract][Full Text] [Related]
24. [Aromatase inhibitors--new horizons in breast cancer endocrine therapy].
Basić-Cabaravdić H
Med Arh; 2005; 59(1):30-2. PubMed ID: 15822681
[TBL] [Abstract][Full Text] [Related]
25. Aromatase inhibitors in early breast cancer treatment.
Mauriac L; Smith I
Semin Oncol; 2003 Aug; 30(4 Suppl 14):46-57. PubMed ID: 14513436
[TBL] [Abstract][Full Text] [Related]
26. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
Jovanović-Mićić D; Beleslin DB; Nikolić SS
Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
[TBL] [Abstract][Full Text] [Related]
27. Systemic adjuvant therapy for breast cancer.
Reed EC
Nebr Med J; 1996 Mar; 81(3):48-50. PubMed ID: 8907820
[TBL] [Abstract][Full Text] [Related]
28. [New developments in hormonal therapy for breast cancer].
Tominaga T
Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
[TBL] [Abstract][Full Text] [Related]
29. Progress in systemic adjuvant therapy of early-stage breast cancer.
Gradishar WJ; O'Regan RM
Int J Clin Oncol; 2003 Aug; 8(4):239-47. PubMed ID: 12955580
[TBL] [Abstract][Full Text] [Related]
30. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
Burstein HJ; Prestrud AA; Seidenfeld J; Anderson H; Buchholz TA; Davidson NE; Gelmon KE; Giordano SH; Hudis CA; Malin J; Mamounas EP; Rowden D; Solky AJ; Sowers MR; Stearns V; Winer EP; Somerfield MR; Griggs JJ;
J Clin Oncol; 2010 Aug; 28(23):3784-96. PubMed ID: 20625130
[TBL] [Abstract][Full Text] [Related]
31. Is adjuvant therapy for older patients with node (-) early breast cancer cost-effective?
Naeim A; Keeler EB
Crit Rev Oncol Hematol; 2005 Jan; 53(1):81-9. PubMed ID: 15607936
[TBL] [Abstract][Full Text] [Related]
32. Role of tamoxifen in the long-term treatment and prevention of breast cancer.
Jordan VC
Oncology (Williston Park); 1988 Sep; 2(9):19-28. PubMed ID: 3079292
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant endocrine therapy for breast cancer: medical perspectives.
Ellis MJ
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4388s-4391s; discussion 4411s-4412s. PubMed ID: 11916229
[TBL] [Abstract][Full Text] [Related]
34. Optimizing endocrine therapy for breast cancer.
Winer EP
J Clin Oncol; 2005 Mar; 23(8):1609-10. PubMed ID: 15755964
[No Abstract] [Full Text] [Related]
35. HER2/neu expression and hormonal therapy in early breast cancer: can muddy waters become clear?
Ferretti G; Di Cosimo S; Giannarelli D; Carlini P; Papaldo P; Alimonti A; Fabi A; Mandalà M; Milella M; Ruggeri EM; Cognetti F
J Clin Oncol; 2004 Feb; 22(3):568-9. PubMed ID: 14752083
[No Abstract] [Full Text] [Related]
36. New developments in endocrine therapy: role of adjuvant therapy for early breast cancer.
Grana G
Cancer Nurs; 2003 Dec; 26(6 Suppl):4S-9S. PubMed ID: 15025406
[TBL] [Abstract][Full Text] [Related]
37. In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.
Fichtner I; Becker M; Zeisig R; Sommer A
Eur J Cancer; 2004 Apr; 40(6):845-51. PubMed ID: 15120040
[TBL] [Abstract][Full Text] [Related]
38. Aromatase inhibitors for hormonal therapy of early-stage breast cancer.
Traina TA; Dickler MN
Curr Opin Investig Drugs; 2004 Jun; 5(6):605-10. PubMed ID: 15242248
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of adjuvant therapy for patients with early-stage (I-IIa) breast cancer].
Semiglazov VF
Vopr Onkol; 1998; 44(2):137-41. PubMed ID: 9615814
[No Abstract] [Full Text] [Related]
40. Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer.
van Hellemond IEG; Geurts SME; Tjan-Heijnen VCG
Curr Treat Options Oncol; 2018 Apr; 19(5):26. PubMed ID: 29704066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
